Pitfalls in estimating piperaquine elimination.

Pitfalls in estimating piperaquine elimination.

By using a sensitive new assay, the terminal elimination half-life of the antimalarial piperaquine in a healthy volunteer was estimated to be 33 days, which is longer than estimated previously. This result illustrates the importance of extended sampling duration and sensitive assay methodologies in...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Tarning, J, Lindegårdh, N, Annerberg, A, Singtoroj, T, Day, N, Ashton, M, White, N
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2005

Gelijkaardige items

Development and validation of an automated solid phase extraction and liquid chromatographic method for the determination of piperaquine in urine.
door: Tarning, J, et al.
Gepubliceerd in: (2006)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
door: Tarning, J, et al.
Gepubliceerd in: (2007)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
door: Tarning, J, et al.
Gepubliceerd in: (2008)

Characterization of human urinary metabolites of the antimalarial piperaquine.
door: Tarning, J, et al.
Gepubliceerd in: (2006)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
door: Tarning, J, et al.
Gepubliceerd in: (2014)

A new approach to evaluate regression models during validation of bioanalytical assays.
door: Singtoroj, T, et al.
Gepubliceerd in: (2006)

A new approach to evaluate regression models during validation of bioanalytical assays
door: Singtoroj, T, et al.
Gepubliceerd in: (2006)

Quantification of the antimalarial piperaquine in plasma.
door: Tarning, J, et al.
Gepubliceerd in: (2008)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
door: Annerberg, A, et al.
Gepubliceerd in: (2011)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
door: Annerberg, A, et al.
Gepubliceerd in: (2011)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
door: Tarning, J, et al.
Gepubliceerd in: (2007)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
door: Tarning, J, et al.
Gepubliceerd in: (2008)

Development and validation of a liquid chromatographic-tandem mass spectrometric method for determination of piperaquine in plasma stable isotope labeled internal standard does not always compensate for matrix effects.
door: Lindegardh, N, et al.
Gepubliceerd in: (2008)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.
door: Ashley, E, et al.
Gepubliceerd in: (2010)

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
door: Ashley, E, et al.
Gepubliceerd in: (2010)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
door: Hoglund, R, et al.
Gepubliceerd in: (2012)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
door: Tarning, J, et al.
Gepubliceerd in: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
door: Tarning, J, et al.
Gepubliceerd in: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
door: Tarning, J, et al.
Gepubliceerd in: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
door: Tarning, J, et al.
Gepubliceerd in: (2012)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
door: Zongo, I, et al.
Gepubliceerd in: (2014)

Identification of an isomer impurity in piperaquine drug substance.
door: Lindegårdh, N, et al.
Gepubliceerd in: (2006)

Automated solid-phase extraction method for the determination of piperaquine in whole blood by rapid liquid chromatography.
door: Lindegårdh, N, et al.
Gepubliceerd in: (2003)

Automated solid-phase extraction method for the determination of piperaquine in plasma by peak compression liquid chromatography.
door: Lindegårdh, N, et al.
Gepubliceerd in: (2003)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
door: Adam, I, et al.
Gepubliceerd in: (2012)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
door: Hoglund Richard M, et al.
Gepubliceerd in: (2012-11-01)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
door: Adam, I, et al.
Gepubliceerd in: (2012)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
door: Smithuis, F, et al.
Gepubliceerd in: (2006)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
door: Rijken, M, et al.
Gepubliceerd in: (2011)

Development and validation of a solid-phase extraction-liquid chromatographic method for determination of amoxicillin in plasma.
door: Lindeg?rdh, N, et al.
Gepubliceerd in: (2005)

Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers
door: Chotsiri, P, et al.
Gepubliceerd in: (2017)

Efficacy and safety of dihydroartemisinin-piperaquine.
door: Myint, H, et al.
Gepubliceerd in: (2007)

High throughput assay for the determination of piperaquine in plasma.
door: Lindeg?rdh, N, et al.
Gepubliceerd in: (2005)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
door: Issaka Zongo, et al.
Gepubliceerd in: (2014-01-01)

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine.
door: Permala, J, et al.
Gepubliceerd in: (2017)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
door: Tarning, J, et al.
Gepubliceerd in: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
door: Tarning, J, et al.
Gepubliceerd in: (2014)

Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention.
door: Bergstrand, M, et al.
Gepubliceerd in: (2014)

High throughput assay for the determination of lumefantrine in plasma.
door: Annerberg, A, et al.
Gepubliceerd in: (2005)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
door: Lwin, K, et al.
Gepubliceerd in: (2012)